Misencik Tiffani
Known title: SVP, Chief Growth OfficerCIK: 0002041258
Associated companies
Transaction History
| CTEV | ▼ Sell | Open Market | 8,850 | $355K | 8/14/2026 | View on chart |
| CTEV | ▼ Sell | Tax Withholding | 1,660 | $22K | 3/1/2026 | View on chart |
| CTEV | ▲ Buy | Grant | 26,342 | $0 | 3/1/2026 | View on chart |
| CTEV | ▼ Sell | Tax Withholding | 7,684 | $425K | 10/14/2025 | View on chart |
| CTEV | ▲ Buy | Grant | 20,247 | $0 | 3/1/2025 | View on chart |
| CTEV | ▲ Buy | Grant | 95,328 | $0 | 10/14/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Claritev Selected by GDIT for WTC Health Program Support
Claritev has been selected by General Dynamics Information Technology (GDIT) to support the World Trade Center Health Program. The financial terms of this agreement were not disclosed. This development adds a notable government-related contract to the company's portfolio, which is relevant context given the stock is currently trading near its 52-week low.
Claritev Selected by GDIT for WTC Health Program Support. Claritev has been selected by General Dynamics Information Technology (GDIT) to support the World Trade Center Health Program. The financial terms of this agreement were not disclosed. This development adds a notable government-related contract to the company's portfolio, which is relevant context given the stock is currently trading near its 52-week low.